Nigel S. Key
University of North Carolina at Chapel Hill · 579 works · 29,177 citations · h-index 83
Top works
- Guidelines for the management of hemophilia
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- Definitions in hemophilia: communication from the SSC of the ISTH
- Home Treatment of Mild to Moderate Bleeding Episodes Using Recombinant Factor VIIa (Novoseven) in Haemophiliacs with Inhibitors
- Sickle blood contains tissue factor–positive microparticles derived from endothelial cells and monocytes
- D-dimer antigen: current concepts and future prospects
- 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
- Iliofemoral Deep Venous Thrombosis: Safety and Efficacy Outcome during 5 Years of Catheter-directed Thrombolytic Therapy
- Role of the Extrinsic Pathway of Blood Coagulation in Hemostasis and Thrombosis
- Whole Blood Tissue Factor Procoagulant Activity Is Elevated in Patients With Sickle Cell Disease
- Standardization of platelet‐derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop
- Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study
- Tissue factor expression by endothelial cells in sickle cell anemia.
- Factor IX Inhibitors and Anaphylaxis in Hemophilia B
- Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia
- Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression.
- Sickle cell trait and the risk of venous thromboembolism among blacks
- Lupus anticoagulant and protein S deficiency in children with postvaricella purpura fulminans or thrombosis